PCSK9 variation and association with blood pressure in African Americans: preliminary findings from the HyperGEN and REGARDS studies

Proprotein convertase subtilisin/kexin type 9 (encoded by PCSK9) plays a well-known role in the regulation of low-density lipoprotein (LDL) receptors, and an inhibitor of this enzyme is a promising new therapeutic for hyperlipidemia. Recently, animal and human studies also implicate PCSK9 genetic va...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Genet
Main Authors: Tran, Ngan T., Aslibekyan, Stella, Tiwari, Hemant K., Zhi, Degui, Sung, Yun Ju, Hunt, Steven C., Rao, DC, Broeckel, Ulrich, Judd, Suzanne E., Muntner, Paul, Kent, Shia T., Arnett, Donna K., Irvin, Marguerite R.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2015
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4389541/
https://ncbi.nlm.nih.gov/pubmed/25904937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2015.00136
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares